ELI LILLY AND COMPANY

(LLY)
  Report
Delayed Nyse  -  04:03 2022-07-06 pm EDT
330.15 USD   +0.91%
07/01Pharmaceutical companies still have the upper hand
06/29GLOBAL MARKETS LIVE : Novartis, Tesla, Disney, Sony, Walmart...
06/29Eli Lilly and Company to Supply an Additional 150,000 Doses of Abcellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide Covid-19 Treatment Options
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on ELI LILLY AND COMPANY
06/06Goldman Sachs Adjusts Eli Lilly and Company Price Target to $276 From $270, Maintains N..
MT
06/01JPMorgan Chase Adjusts Price Target for Eli Lilly and Company to $355 From $340, Reiter..
MT
05/23SVB Securities Initiates Eli Lilly and Co. at Outperform With $341 Price Target
MT
05/13Berenberg Bank Adjusts Eli Lilly's Price Target to $345 From $305, Maintains Buy Rating
MT
05/10UBS Adjusts Eli Lilly and Company Price Target to $293 From $267, Maintains Neutral Rat..
MT
05/02Guggenheim Adjusts Eli Lilly's Price Target to $333 From $292, Reiterates Buy Rating
MT
05/02Mizuho Securities Adjusts Eli Lilly's Price Target to $356 From $315, Reiterates Buy Ra..
MT
04/29BMO Capital Adjusts Eli Lilly and Company Price Target to $358 From $330, Maintains Out..
MT
04/29Morgan Stanley Adjusts Eli Lilly and Co.'s Price Target to $369 from $364, Keeps Overwe..
MT
04/29JPMorgan Adjusts Price Target for Eli Lilly and Company to $340 From $325, Maintains Ov..
MT
04/29Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $270 From $264, Maintai..
MT
04/29Wells Fargo Raises Eli Lilly and Company's Price Target to $305 From $280, Equalweight ..
MT
04/14Mizuho Adjusts Price Target for Eli Lilly and Company to $315 From $293, Maintains Buy ..
MT
04/12Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $264 From $234, Maintai..
MT
04/06Morgan Stanley Adjusts Eli Lilly and Co.'s Price Target to $364 from $265, Keeps Overwe..
MT
03/17BofA Securities Raises Eli Lilly and Company's Price Target to $315 From $300, Maintain..
MT
03/10Daiwa Securities Starts Eli Lilly at Outperform With $286 Price Target
MT
03/10ANALYST RECOMMENDATIONS : Broadcom, Cisco, Eli Lilly, Experian, NetApp...
02/04Goldman Sachs Raises Price Target for Eli Lilly and Company to $234 From $231, Maintain..
MT
02/04Morgan Stanley Lowers Price Target for Eli Lilly and Company to $265 From $272, Maintai..
MT
02/04BMO Capital Lowers Price Target for Eli Lilly and Company to $305 From $310, Maintains ..
MT
01/24Morgan Stanley Adjusts Eli Lilly and Co.'s Price Target to $272 from $275, Keeps Overwe..
MT
01/21DZ Bank Upgrades Eli Lilly and Co. to Buy From Hold; Price Target is $291
MT
01/05Mizuho Securities Adjusts Eli Lilly's Price Target to $302 From $272, Reiterates Buy Ra..
MT
01/04Wells Fargo Adjusts Eli Lilly and Co.'s Price Target to $280 from $270, Keeps Equalweig..
MT
2021Berenberg Bank Adjusts Eli Lilly and Company PT to $305 From $270, Maintains Buy Rating
MT
2021Barclays Adjusts Eli Lilly's Price Target to $325 From $280, Reiterates Overweight Rati..
MT
2021Goldman Sachs Starts Eli Lilly at Neutral With $236 Price Target
MT
2021BMO Capital Adjusts Eli Lilly's Price Target to $320 From $311, Keeps Outperform Rating
MT
2021JPMorgan Adjusts Eli Lilly's Price Target to $325 From $300, Reiterates Overweight Rati..
MT
2021Wedbush Raises Price Target for Foghorn Therapeutics to $32 From $24 on Eli Lilly Colla..
MT
2021ANALYST RECOMMENDATIONS : Biogen, Eli Lilly, Microsoft, Tesla, Weibo
2021Wells Fargo Starts Eli Lilly at Equalweight With $270 Price Target
MT
2021Truist Securities Adjusts Eli Lilly and Co.'s Price Target to $301 from $262, Keeps Buy..
MT
2021BMO Capital Starts Eli Lilly at Outperform With $311 Price Target
MT
2021Mizuho Securities Adjusts Eli Lilly and Co.'s Price Target to $272 From $279, Reiterate..
MT
2021ELI LILLY AND : Upgraded to Buy From Hold by Berenberg, Price Target Boosted to $270 From ..
MT
2021ELI LILLY AND : Citigroup Upgrades Eli Lilly to Buy from Neutral, Adjusts PT to $265 from ..
MT
2021ELI LILLY AND : Berenberg Bank Raises Price Target on Eli Lilly to $240 From $190, Maintai..
MT
2021ELI LILLY AND : Cowen Adjusts Eli Lilly and Co.'s Price Target to $300 from $250, Keeps Ou..
MT
2021ELI LILLY AND : Cantor Fitzgerald Adjusts Eli Lilly and Company PT to $315 From $300, Main..
MT
2021ELI LILLY AND : Argus Adjusts Eli Lilly's Price Target to $300 From $225, Maintains Buy Ra..
MT
2021JPMorgan Adjusts Price Target for Eli Lilly and Company to $300 From $270, Maintains Ov..
MT
2021ELI LILLY AND : Morgan Stanley Adjusts Price Target on Eli Lilly to $275 From $207, Mainta..
MT
2021ELI LILLY AND : DZ Bank Upgrades Eli Lilly to Buy From Hold; Price Target is $288
MT
2021ANALYST RECOMMENDATIONS : Barclays, Domino's Pizza, Eli Lilly, Experian, Walmart...
2021ELI LILLY AND : Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $302 From ..
MT
2021ELI LILLY AND : JPMorgan Adjusts Price Target for Eli Lilly and Company to $300 From $270,..
MT
2021ELI LILLY AND : Mizuho Securities Adjusts Eli Lilly's Price Target to $279 From $250, Reit..
MT
2021ELI LILLY AND : Morgan Stanley Adjusts Eli Lilly's Price Target to $275 From $207, Reitera..
MT
2021ELI LILLY AND : Barclays Adjusts Eli Lilly's Price Target to $250 From $227, Keeps Overwei..
MT
2021ELI LILLY AND : Truist Securities Adjusts Eli Lilly's Price Target to $262 From $225, Main..
MT
2021ANALYST RECOMMENDATIONS : Accenture, Comcast, DoorDash, Intel, Roku...
2021ELI LILLY AND : Mizuho Adjusts Price Target on Eli Lilly to $250 From $216, Maintains Buy ..
MT
2021ELI LILLY AND : Cantor Fitzgerald Adjusts Eli Lilly's Price Target to $300 From $245, Reit..
MT
2021ELI LILLY AND : Cowen Adjusts Eli Lilly's Price Target to $250 From $235, Keeps Outperform..
MT
2021ELI LILLY AND : JPMorgan Adjusts Price Target on Eli Lilly to $260 From $240, Maintains Ov..
MT
2021ELI LILLY AND : Bernstein Adjusts Price Target on Eli Lilly to $250 From $205, Maintains M..
MT
2021ELI LILLY AND : Goldman Sachs Adjusts Eli Lilly's Price Target to $270 From $252, Keeps Co..
MT
2021ELI LILLY AND : UBS Adjusts Eli Lilly's Price Target to $193 From $170, Modeling Higher Pr..
MT
2021ELI LILLY AND : Mizuho Adjusts Price Target for Eli Lilly and Company to $216 From $228, M..
MT
2021ELI LILLY AND : Goldman Sachs Adjusts Price Target for Eli Lilly and Company to $252 From ..
MT
2021ELI LILLY AND : Barclays Adjusts Price Target on Eli Lilly to $227 From $232, Maintains Ov..
MT
2021ELI LILLY AND : Morgan Stanley Cuts Price Target on Eli Lilly to $207 From $217, Maintains..
MT
2021ELI LILLY AND : Truist Securities Adjusts Eli Lilly and Co.'s Price Target to $225 from $2..
MT
2021ELI LILLY AND : Morgan Stanley Adjusts Eli Lilly's Price Target to $217 From $190, Maintai..
MT
2021ELI LILLY AND : Truist Securities Adjusts Price Target for Eli Lilly to $215 From $200, Ma..
MT
2021ELI LILLY AND : Goldman Sachs Adjusts Price Target for Eli Lilly to $256 From $227, Mainta..
MT
2021ELI LILLY AND : Barclays Adjusts Price Target for Eli Lilly to $232 From $190, Maintains O..
MT
2021ELI LILLY AND : JP Morgan Adjusts Price Target for Eli Lilly to $240 From $200, Maintains ..
MT
2021ELI LILLY AND : Mizuho Adjusts Eli Lilly and Co.'s Price Target to $228 From $222, Keeps B..
MT
2021ELI LILLY AND : Berenberg Adjusts Eli Lilly's Price Target to $190 From $150, Reiterates H..
MT
2021ELI LILLY AND : BofA Securities Adjusts Eli Lilly and Company PT to $225 From $195, Mainta..
MT
2021ELI LILLY AND : Mizuho Upgrades Eli Lilly and Co. to Buy from Neutral, Adjusts Price Targe..
MT
2020ELI LILLY AND : UBS Adjusts Price Target on Eli Lilly and Co. to $170 From $166, Maintains..
MT
1  2Next
Official Publications
Upcoming event on ELI LILLY AND COMPANY